Localised osteoarthritis and drugs of ingredients of prednisolone - a phase IV clinical study of FDA data


Summary:

Localised osteoarthritis is found among people who take drugs with ingredients of prednisolone, especially for people who are female, 30-39 old . This phase IV clinical study is created by eHealthMe based on reports of 165,620 people who have side effects when taking drugs with ingredients of prednisolone from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Cortalone, Delta-cortef, Fernisolone-p, Meti-derm, Prednisolone, Prelone, Sterane.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.


On Jun, 28, 2022

165,620 people reported to have side effects when taking drugs with ingredients of prednisolone.
Among them, 7 people (0.0%) have Localised osteoarthritis


What is Localised osteoarthritis?

Localised osteoarthritis (infection of joint affects only single joint) is found to be associated with 364 drugs and 109 conditions by eHealthMe.

Number of reports submitted per year:

Could drugs with ingredients of prednisolone cause Localised osteoarthritis?

Gender of people who have Localised osteoarthritis when taking drugs with ingredients of prednisolone *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Localised osteoarthritis when taking drugs with ingredients of prednisolone *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 71.43 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 28.57 %

Conditions people have *:

  1. Menstruation Irregular: 5 people, 71.43%

Other drugs people take *:

  1. Yasmin: 5 people, 71.43%
  2. Vioxx: 5 people, 71.43%
  3. Sandimmune: 5 people, 71.43%
  4. Lexapro: 3 people, 42.86%
  5. Torsemide: 2 people, 28.57%
  6. Theophylline: 2 people, 28.57%
  7. Enalapril Maleate: 2 people, 28.57%
  8. Alendronate Sodium: 2 people, 28.57%
  9. Pravastatin Sodium: 1 person, 14.29%
  10. Morphine Sulfate: 1 person, 14.29%

Other side effects people have besides Localised osteoarthritis *:

  1. Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 6 people, 85.71%
  2. Visual Disturbance: 5 people, 71.43%
  3. Head Injury: 5 people, 71.43%
  4. Joint Effusion (presence of extra fluid in joint covering): 5 people, 71.43%
  5. Intracranial Venous Sinus Thrombosis (presence of thrombosis (a blood clot) in the dural venous sinuses, which drain blood from the brain): 5 people, 71.43%
  6. Indigestion: 5 people, 71.43%
  7. Hypochromic Anaemia (hypochromic anaemia is a generic term for any type of anaemia in which the red blood cells (erythrocytes) are paler than normal): 5 people, 71.43%
  8. Hot Flush (sudden feelings of heat): 5 people, 71.43%
  9. Heart Rate Irregular: 5 people, 71.43%
  10. Headache (pain in head): 5 people, 71.43%

* Approximation only. Some reports may have incomplete information.


How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Drugs with ingredients of prednisolone, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on prednisolone. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: